Therapeutic Efficacy of Phytosterols on Metabolic Syndrome

Universidad de los Andes, Chile220 enrolled

Overview

The objective is to evaluate therapeutic efficacy of 2 grams nano-phytosterols daily supplemention on diagnosis criteria of metabolic syndrome.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

220

Conditions

Metabolic Syndrome x

Interventions

PhytosterolsDIETARY_SUPPLEMENT

Oral daily consumption of 2 grams of phytosterols (8 ml) per 180 days.

Titanium DioxideDIETARY_SUPPLEMENT

Oral daily consumption of Titanium Dioxide (8 ml) per 180 days.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Informed consent written * Available subjects to follow-up visits * Subjects with diagnoses of metabolic syndrome 5 years ago or with current diagnoses criteria * Subjects with health visits ongoing * Subjects with arterial hypertension under control. * Subjects with mellitus diabetes under control. Exclusion Criteria: * Subjects with alcoholism history. * Subjects with history of sitosterolemia. * Subjects with familiar hypercholesterolemia * Subjects who are consuming phytosterols * Pregnancy women * Breastfeeding period women * Subjects with personal history of: acute miocardical infarction, stroke, hypertensive emergency, acute or chronic diabetes descompensation

Locations (1)

Universidad de Los Andes

Santiago, Chile

Outcomes

Primary Outcomes

Difference of proportion between study groups in the proportion of metabolic syndrome from baseline and the last visit (180 days).

Time frame: 180 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.